Mapping of the Human Brainstem During Continence and Micturition: Noninvasive 7-T fMRI Study

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Healthy
Interventions
DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

"A T1-weighted Anatomical Image, Diffusion Weighted Image, and functional MRI (fMRI) of empty bladder image will be obtained.~Additionally, fMRI image during full bladder state and voiding/holding tasks will be obtained."

DIAGNOSTIC_TEST

Post-Void Residual

The patient's post-void residual is determined using a portable ultrasound machine after emptying the bladder just prior to entering the MRI scanner and immediately after the MRI scan.

DIAGNOSTIC_TEST

Uroflowmetry

Patients will urinate into a funnel connected to an electric flow meter to record urine flow rates in mililters per second. This is used as part of the screening process.

BEHAVIORAL

Questionaire - AUA Symptom Score

Subjects will fill out questionnaire asking about urinary symptoms. The range is 0-35.

Trial Locations (1)

77030

Houston Methodist Hospital, Houston

All Listed Sponsors
lead

The Methodist Hospital Research Institute

OTHER

NCT04846387 - Mapping of the Human Brainstem During Continence and Micturition: Noninvasive 7-T fMRI Study | Biotech Hunter | Biotech Hunter